Tuesday, November 10, 2015
- 9:00AM-11:00AM
-
Abstract Number: 2932
A Retrospective Observational Study of Patients with Lupus Nephritis Treated with Rituximab in Combination with Cyclophosphamide
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session III- 9:00AM-11:00AM
-
Abstract Number: 2989
A Romanian Version of the University of Californa at Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT 2.0) Instrument
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster III- 9:00AM-11:00AM
-
Abstract Number: 2351
A Study to Evaluate the Pharmacodynamics, Pharmacokinetics and Safety of Arhalofenate in Combination with Febuxostat When Treating Hyperuricemia Associated with Gout
Metabolic and Crystal Arthropathies Poster II- 9:00AM-11:00AM
-
Abstract Number: 2831
A Subset of Natural Killer Cells Are Expanded in Synovial Fluid of Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis
Spondylarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology Poster II- 9:00AM-11:00AM
-
Abstract Number: 2909
A Systematic Review and Meta-Analysis of Cutaneous Manifestations in Late Versus Early-Onset Systemic Lupus Erythematosus
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session III- 9:00AM-11:00AM
-
Abstract Number: 2705
AAA-Atpase p97-HDAC6 Controlled Poly-Ubiquitin Turnover Regulates Apoptotic and Autophagy-Associated Cell Death in Arthritis
Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster III- 9:00AM-11:00AM
-
Abstract Number: 2361
Abatacept in the Treatment of Adult Dermatomyositis and Polymyositis: a Randomized, Treatment Delayed-Start Trial
Muscle Biology, Myositis and Myopathies Poster II: Autoantibodies and Treatments in Inflammatory Myopathies- 9:00AM-11:00AM
-
Abstract Number: 2778
Abatacept-Treated Rheumatoid Arthritis Patients Have Better Drug-Survival Rate When Abatacept Is the First or Second Line Biologic Agent with an Excellent Overall Safety Profile: A Single Center Experience
Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster III- 9:00AM-11:00AM
-
Abstract Number: 2577
Ablation of Fc Gamma Receptors Leads to a Decreased Bone Erosion in Experimental Arthritis Not By Altering Osteoclast Numbers within the Inflamed Joint but By Inhibiting Osteoclast Activation
Rheumatoid Arthritis - Animal Models Poster- 9:00AM-11:00AM
-
Abstract Number: 3059
Abnormal Body Composition in Takayasu Arteritis Patients: Role of Inflammatory Cytokines and Adipokines
Vasculitis Poster III- 9:00AM-11:00AM
-
Abstract Number: 2781
Absence of Effects of Filgotinib on Erythrocytes, CD8+ and NK Cells in Rheumatoid Arthritis Patients Brings Further Evidence for the JAK1 Selectivity of Filgotinib
Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster III- 9:00AM-11:00AM
-
Abstract Number: 2444
Accelerometer-Assessed Daily Physical Activity in Relation to Pain Cognitions and Quality of Life in Juvenile Idiopathic Arthritis
Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters (ACR): Imaging and Novel Clinical Interventions- 9:00AM-11:00AM
-
Abstract Number: 2740
ACPA Positivity in the Elderly and Concomitant MTX Use in Younger May be Useful Predictive Factors for Superior Clinical Efficacy with Abatacept in Japanese Biological-Naïve RA Patients
Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster III- 9:00AM-11:00AM
-
Abstract Number: 2565
ACPA Specific IVIG Attenuate Collagen Induced Arthritis in Mice